Innovating Works

THERENVA

Desconocido
EurValve: Personalised Decision Support for Heart Valve Disease THERENVA participó en un H2020: H2020-PHC-2014-2015 Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise...
2015-11-10 - 2019-01-31 | Financiado
VPH-CaSE: VPH Cardiovascular Simulation and Experimentation for Personalised Medical Devices THERENVA participó en un H2020: H2020-MSCA-ITN-2014 VPH-CaSE is focused on state-of-the-art developments in personalised cardiovascular support, underpinned by simulation and experimentation,...
2014-12-16 - 2018-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.